Global Yellow Fever Vaccine Market
Pharmaceuticals

Yellow Fever Vaccine Market Forecast 2026: Where the Industry Is Headed

Uncover key drivers, emerging technologies, and competitive movements shaping the yellow fever vaccine market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Yellow Fever Vaccine Market between 2026 and 2030?

The yellow fever vaccine market size has consistently expanded in recent years. This market is anticipated to increase from $4.74 billion in 2025 to $4.97 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.8%. Historically, the growth witnessed in this sector has been largely due to recurring yellow fever outbreaks, government immunization mandates, established vaccine efficacy, international travel requirements, and various public health initiatives.

The yellow fever vaccine market is projected to experience consistent expansion over the upcoming years. By 2030, its valuation is anticipated to reach $5.88 billion, demonstrating a compound annual growth rate (CAGR) of 4.3%. This forecasted growth is primarily driven by factors such as climate-driven mosquito dispersion, a rise in international travel, the broadening of vaccination infrastructure, increased financial investment in disease prevention, and enhanced outbreak preparedness measures. Key trends expected during this period encompass the enlargement of routine immunization initiatives, a growing need from travelers crossing borders, more extensive government-sponsored vaccination drives, an increasing preference for single-dose vaccines, and a concentrated effort on preventing endemic diseases.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp

Which Drivers Are Expected To Impact The Yellow Fever Vaccine Market During The Forecast Period?

The yellow fever vaccine market is anticipated to grow as international travel increases. This refers to the movement of individuals across national borders for purposes such as tourism, business, or personal visits. The rise in international travel is being driven by increasing global mobility, supported by economic recovery and the easing of post-pandemic travel restrictions. The yellow fever vaccine market caters to travelers by providing essential or recommended immunizations required for entry into regions where yellow fever is widespread. For instance, in January 2024, the World Tourism Organization (UNWTO), an international tourism agency based in Spain, reported that global international tourist arrivals reached 1.286 billion in 2023. This figure is significantly higher than the 0.96 billion recorded in 2022, marking an increase of 0.326 billion international tourists year-on-year. Therefore, the growth of the yellow fever vaccine market is being propelled by the surge in international travel.

Which Segments Are Driving Activity In The Yellow Fever Vaccine Market?

The yellow fever vaccine market covered in this report is segmented –

1) By Product: Powder, Liquid

2) By Application: Routine Immunization, Travelers, Other Applications

3) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:

1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution

2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

Which Trends Are Shaping Activity Within The Yellow Fever Vaccine Market?

Leading companies in the yellow fever vaccine market are increasingly focusing on developing innovative solutions, such as T-cell adaptive booster vaccines, to enhance long-term immunity, improve vaccine efficacy, and address the limitations of traditional live-attenuated vaccines. T-cell adaptive booster vaccines are designed to strengthen the immune system by specifically enhancing T-cell responses, which help the body recognize and fight infections more effectively compared to traditional antibody-focused vaccines. For instance, in April 2025, the All India Institute of Medical Sciences, an India-based healthcare institute, launched Yellow Fever Vaccination to provide travelers with protection against the mosquito-borne viral disease and issue the internationally recognized vaccination certificate. This initiative aims to increase accessibility to the vaccine within Telangana, reducing the need for long-distance travel to other authorized centers. Additionally, the program ensures adherence to international health regulations by offering safe administration under medical supervision, particularly for individuals with contraindications.

Which Key Players Are Driving Competition In The Yellow Fever Vaccine Market?

Major companies operating in the yellow fever vaccine market are Sanofi S.A., Bio-Manguinhos, Institut Pasteur de Dakar, Instituto Butantan, Bio Farma, Biological E. Limited, Beijing Tiantan Biological Products Co. Ltd., Wuhan Institute of Biological Products, Merck & Co. Inc., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Lonza Group AG, WuXi Biologics, Ology Bioservices, Valneva SE, Bavarian Nordic A/S, Panacea Biotec Ltd., Biovac, Novavax Inc., PnuVax Incorporated

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Which Region Is Projected To Lead The Yellow Fever Vaccine Market During The Forecast Period?

North America was the largest region in the yellow fever vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Yellow Fever Vaccine Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=17297&type=smp

Browse Through More Reports Similar to the Global Yellow Fever Vaccine Market 2026, By The Business Research Company

Yellow Fever Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Yellow Fever Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model